Archives
-
SEMA3E, β-Catenin, and Beige Fat Thermogenesis
2026-08-14
This mouse study identifies SEMA3E as a functional regulator of beige adipocyte differentiation and cold-induced thermogenesis, linking its activity to mitochondrial oxidative phosphorylation and Wnt/β-catenin signaling. The findings provide a mechanistic framework for studying adipose remodeling and indicate how SEMA3E perturbation could be evaluated alongside established PPARγ and metabolic research workflows.
-
Chloroquine Diphosphate in Autophagy Assays
2026-08-14
Chloroquine Diphosphate is more than a conventional autophagy inhibitor: it is a practical perturbation tool for separating autophagic flux, apoptosis, and ferroptosis in cancer research. This guide translates mechanistic findings from resistant colorectal cancer models into better assay and combination-treatment decisions.
-
Thioguanine: Reliable Cell Assay Workflows
2026-08-13
Learn how Thioguanine, SKU A4176, can support more interpretable viability, proliferation, cytotoxicity, and antiviral assays through controlled solubility, documented purity, and model-specific benchmark data. This scenario-based guide addresses assay variability, stock preparation, endpoint interpretation, and practical product selection.
-
Sunitinib Workflows for RCC Angiogenesis Research
2026-08-13
Build reproducible Sunitinib assays that connect RTK blockade with angiogenesis, apoptosis, and metabolic resistance in renal cell carcinoma models. This practical guide covers dose-response design, combination testing with glycolysis-focused strategies, and troubleshooting for resistant-cell workflows.
-
Mildronate-Derived Lipidoids for Safer mRNA Vaccines
2026-08-12
The 2024 ACS Nano study developed mildronate-derived cationic lipidoids and formulated them into mLNP-69, an mRNA delivery system designed to retain efficient transfection while reducing local inflammation. In prophylactic and therapeutic B16OVA melanoma models, mLNP-69 enabled effective cancer-vaccine delivery, supporting low-dose lipid design as a practical direction for preclinical vaccine development research.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-12
The reference study shows that puerarin enhances osteogenic differentiation of rat dental follicle cells alongside increased nitric oxide, cGMP, and osteogenic marker expression. Pharmacological inhibition with L-NMMA weakened these responses, supporting a functional role for NO signaling while leaving important questions about dose, cell specificity, and in vivo periodontal regeneration.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflow Guide
2026-08-11
Build a transient Cre-lox recombination pulse with modified, Cap 1-capped mRNA rather than relying on persistent genetic delivery. This practical guide connects cell-based assay design with emerging extrahepatic delivery systems, including the EVMP platform described in ACS Nano.
-
MIR9 Epigenetic Silencing Drives FGFR1 and CDK6 in ALL
2026-08-11
The reference study links MIR9-family hypermethylation with reduced microRNA expression, activation of FGFR1 and CDK6, and poorer outcomes in acute lymphoblastic leukaemia. Its combination of patient-level methylation analysis, survival modelling, and inhibitor experiments provides a mechanistic framework for biomarker development and pathway-directed research.
-
RITA (NSC 652287): Measure Killing, Not Just Viability
2026-08-10
RITA (NSC 652287) can reveal why a cancer cell assay changes by separating growth inhibition from actual cell killing. This guide applies that framework to p53-focused cancer biology, renal carcinoma research, apoptosis assays, and tumor xenograft interpretation.
-
EZ Cap™ Cre mRNA (m1Ψ): Assay Design Guide
2026-08-09
Learn how EZ Cap™ Cre mRNA (m1Ψ) converts Cre-lox biology into a controllable, transient editing pulse. This guide connects mRNA chemistry, assay controls, and emerging extrahepatic delivery strategies for better experimental decisions.
-
Antiarrhythmic Drugs and Cardiac SK Channels
2026-08-08
The 2017 reference study used automated whole-cell patch clamp to test whether established antiarrhythmic drugs modulate human small-conductance calcium-activated potassium channels. Dofetilide and propafenone inhibited hKCa2.2 and hKCa2.3, whereas the broader drug panel, including dronedarone, showed no clinically compelling inhibition, helping distinguish therapeutic mechanisms from off-target channel activity.
-
Artemisinin, NRF2, and Ferroptosis in Diabetic Cognition
2026-08-07
Wang et al. show that artemisinin improves learning and memory deficits in STZ-induced type 2 diabetes mellitus mice while reducing ferroptosis-related injury in hippocampal CA1 neurons. Pharmacological blockade of NRF2 with ML385 and induction of ferroptosis with erastin weakened these benefits, supporting an NRF2–GPX4 antioxidant mechanism rather than a nonspecific behavioral effect.
-
Instant Clot-Forming Antibacterial Dressings with Tranexamic
2026-08-07
The reference study introduces a bi-layer wound dressing that rapidly achieves hemostasis and antibacterial protection using a combination of tranexamic acid, propolis, and a nitric oxide donor. This work demonstrates significant reductions in bleeding and infection risk, supporting advances in trauma care and translational fibrinolysis research.
-
TAK1-Mediated YAP Stabilization Drives Gastric Cancer Stemne
2026-08-06
This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP) in gastric cancer stem cells, enhancing their self-renewal and oncogenic potential. The findings reveal a mechanistic link with direct implications for targeting stemness and therapy resistance in gastric cancer.
-
Paclitaxel (Taxol) Workflows: Precision in Cancer Research M
2026-08-06
Paclitaxel (Taxol) stands out as a gold-standard microtubule modulator, enabling advanced cancer modeling and drug response profiling. Discover how optimized protocols and patient-derived assembloid systems deliver translational impact and reproducible insights.
552 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page